Other than expressing your frustrations at the time it takes to run the trials , expand the trials and deliver the results, was there a point to your post that I’m missing here.
Dr Bradley Glover clearly stated that IMU was looking at expanding into several specific indications . This news should be available for us all to see within a month or two.
At this point we are very close to reaching OBD in the mono arms of mast. That’s when the pace really picks up for recruitment. It’s obviously very difficult for many holders showing patience especially whilst the range bound shareprice is being so stubborn at this level. A bit like building your first home. It looks built and nearly finished forever before the builder hands over the keys.
This long flat sideways spell is nearly over, We will be flooded with data and news over the next 3 months. Remembering it only took 3 weeks from data to Fast Track for bile duct cancer. We could reasonably expect 2-3 more fast tracks in the next 3 months.
Dr Glover also mentioned Monil Shah . And if we have 3-4 Fast Tracks in hand you can rest assured Monil will be busier than a one armed paper hanger. The BP companies will be kicking down his door.
ARE WE THER YET????? Just a little bit further. Not long now!
IMU Price at posting:
10.5¢ Sentiment: Buy Disclosure: Held
(20min delay)
